Canntab Therapeutics Limited Stock

Stocks

24-04-14

23-09-18	Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order	NE
22-08-02	CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO	PR
22-05-30	CANNTAB ANNOUNCES CHANGE OF AUDITOR	PR
22-03-23	CANNTAB SIGNS AFFILIATE AGRREMENT WITH ONPHARM-UNITED	PR
22-01-20	CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM	PR

1 day

-99.00%

Manager	Title	Age	Since
Joshi Laxminarayan CTO	Chief Tech/Sci/R&D Officer	-	2020-05-14
Frank Candido IRC	Investor Relations Contact	61	2018-08-31
Eric Malinski SAM	Sales & Marketing	-	2018-04-30

Date	Insider	Type	Main position	Quantity	% Market Cap.
24-02-05	Vitor Fonseca	Option	Director	100,000	0.2570%
24-02-05	Vitor Fonseca	Option	Director	100,000	0.2570%
22-02-21	Richard Goldstein	Option	Chief Executive Officer	400,000	1.0717%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANNTAB THERAPEUTICS LIMITED	-99.00%	-.--%	-	-	38
YUNNAN BAIYAO GROUP CO.,LTD	+0.21%	+3.96%	-12.42%	-6.67%	12.84B
BEIJING TONGRENTANG CO., LTD	+0.34%	+4.33%	-34.60%	-58.14%	4.72B
DONG-E-E-JIAO CO., LTD.	-0.02%	+8.30%	-7.96%	-4.77%	4.46B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.23%	+12.59%	+23.21%	-4.45%	3.91B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+1.10%	+6.55%	+4.13%	-38.94%	3.84B
TASLY PHARMACEUTICAL GROUP CO., LTD	+1.74%	+5.74%	-12.12%	+0.14%	3.08B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	+0.13%	-11.54%	-13.71%	-19.23%	3.05B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.79%	+6.47%	-7.94%	-24.93%	2.38B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+0.53%	+7.02%	-11.86%	+34.52%	1.72B
Average	-9.20%	+0.07%	-8.14%	-13.61%	4.45B
Weighted average by Cap.	+0.64%	+0.26%	-9.25%	-15.16%